Warner Chilcott (US), LLC et al v. Teva Pharmaceuticals USA, Inc. et al, No. 2:15-cv-01471 (E.D. Tex. Aug. 10, 2017)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Plaintiffs object to Magistrate Judge Payne ’s recommendation that Plaintiffs ’ motion to dismiss Teva Pharmaceuticals USA, Inc. (“Teva”) for lack of subject matter jurisdiction be denied. Dkt. 218. Having reviewed Plaintiffs’ objections, and having considered Judge Payne’s Report and Recommendation de novo, the Court finds no reason to reject or modify the recommended disposition. See Fed. R. Civ. P. 72(b)(3); 28 U.S.C. § 636(b)(1)(C). Accordingly, it is ORDERED: (1) Plaintiffs’ objections, Dkt. 218, are OVERRULED.